rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2003-7-10
|
pubmed:abstractText |
In HIV-positive individuals administration of intermittent interleukin (IL)-2 in addition to highly active antiretroviral therapy (HAART) induces expansion of the peripheral T cell pool with dilution of signal joint T cell receptor excision circles (sjTREC) that cannot be used to measure thymic output. We analysed whether in vitro thymopoiesis could be used to predict in vivo thymic output in IL-2 treated subjects.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0269-9370
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1621-30
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12853744-Adult,
pubmed-meshheading:12853744-Animals,
pubmed-meshheading:12853744-Anti-HIV Agents,
pubmed-meshheading:12853744-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:12853744-CD4 Lymphocyte Count,
pubmed-meshheading:12853744-CD4-Positive T-Lymphocytes,
pubmed-meshheading:12853744-Cells, Cultured,
pubmed-meshheading:12853744-Female,
pubmed-meshheading:12853744-Flow Cytometry,
pubmed-meshheading:12853744-HIV Infections,
pubmed-meshheading:12853744-HIV-1,
pubmed-meshheading:12853744-Humans,
pubmed-meshheading:12853744-Interleukin-2,
pubmed-meshheading:12853744-Lymphopoiesis,
pubmed-meshheading:12853744-Mice,
pubmed-meshheading:12853744-Mice, Inbred C57BL,
pubmed-meshheading:12853744-Middle Aged,
pubmed-meshheading:12853744-Virus Replication
|
pubmed:year |
2003
|
pubmed:articleTitle |
Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administration.
|
pubmed:affiliation |
Dipartimento di Biologia e Genetica per le Scienze Mediche, Università di Milano, Milano, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|